Cyclacel Pharmaceuticals Inc (CYCC) — Capital Reinvestment Ratio

Latest as of December 2009: 0.00x

Cyclacel Pharmaceuticals Inc (CYCC) has a Capital Reinvestment Ratio of 0.00x as of December 2009, meaning it reinvests 0% of its operating cash flow ($12.62 Million) in capital expenditures ($2.00K). See Cyclacel Pharmaceuticals Inc (CYCC) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$12.62 Million
USD

Capital Expenditures

$2.00K
USD

Data as of

Dec 2009
Most recent filing

Annual Capital Reinvestment Ratio for Cyclacel Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Cyclacel Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see Cyclacel Pharmaceuticals Inc market cap and net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow